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Tissue inhibitors ofnxtalloprotcinases (TIMPs) constitute afamily of secreted glycoprotcins involved in rcgulatingcxtracellular matrix degradation 
in both normal and malignant issues. WC have expressed a cDNA clone of mouse TIMP-I as a 22-kDa protein with 12 cysteinc residues in E. 
CO/I’ and purilied protein that shows inhibitory activity agains collagcnasc following rcnnturation by chemical means. The low specific activity and 
circular dichroism measurements suggest, howcvcr, that the rrnaturation of ~hc mouse recombinant (non-glycosylatcd) protein is not cfficicnt under 
the condhions WC have used, indicative of eilhcr thermodynamic instability or the transition to kinetic intcrmcdiatcs which hnvc very low in vitro 
refolding rates, 
Tissue inhibitor of mctalloproteinasc: Collagcnase; Collagen; Protein refolding 
1, INTRODUCTlON 
Matrix metalloprotcinases (MMPs) make up the col- 
lagenase gene family (which includes interstitial collage- 
nasc, MMP-I; stromclysin, M’MP-II, and type IV col- 
lagenasc, MMP-III); they are effective in the degrada- 
tion and turnover of extracellular matrices, which are 
composed of collagens, proteoylycans, and glycopro- 
teins such as Abronectin and laminin [1,2]. Activation 
of the proenzyme forms of the MMPs secreted by con- 
nective tissue cells and inhibition of these enzymes by 
specific inhibitor proteins (TIMP; or tissue inhibitor of 
metalloproteinase) are two points at which breakdown 
of connective-tissue matrix may be controlled. 
cells [ 12,131 and extended them by revealing for the first 
time an unexpected role for TIMP as a tumor suppres- 
sor. 
TIMP-1 [3-83 is a 28%kDa glycoprotein that forms 
a I: I complex with activated interstitial collagenase [3- 
5] and occurs ubiquitously among tissues and species 
(for review see [2]). As with matrix metalloproteinases, 
a family of TIMPs exists, the two members most vigor- 
ously studied being the 2&S-kDa protein (TIMP-1) [3- 
8] and the 21.kDa protein (TlMP-2) [9,10]. Khokha et 
al, [l l] recently showed that down-regulation of TIMP- 
1 mRNA levels via antisense RNA resulted in the con- 
version of immortal, non-tumorigenic and non-invasive 
Swiss 3T3 cells into invasive, tumorigenic and metas- 
tatic cells. These results corroborated previous observa- 
tions of an inverse correlation between TIMP levels and 
the ilrvasive potential of both mouse and human tumor 
Although it has been found that the N-terminal do- 
main of TIMP is involved in metalloproteinase inhib- 
itory activity [14], the exast mechanism of TIMP bind- 
ing and inhibition of MMPs is unknown. To understand 
how TIMP interacts with the MMPs we have sought to 
produce TIMP in quantities large enough to study. WC 
chose a host-vector system in which TIMP is made in 
E. coli as an intracellular inclusion body. Since TlMP 
in this intracellular structure is found as a complex of 
inactive, aggregated protein, the inactive species must 
be purified and rcnatured in vitro. Here, we report the 
synthesis in E. cu!i of inactive TIMP-1 (a non-glycosyl- 
ated 22-kDa protein), its purification from inclusion 
bodies, and its refolding to a form presumably contain- 
ing 12 disulfide bonds [I 51. 
2. MATERIALS AND METHODS 
?. 1. Cammcriorl of TIMP-I expression wcror 
Ahbreeiurions: IPTG, isopropylthiopalactoside; TFA, lrifluoroacclic 
acid; HPLC, high performance liquid chromatography; collagcnolysis 
inhibition. 
In order to express mouse TIMP-1 (henceforth written as mTIMP- 
I) in E. coli we employed PET-3c, a plasmid vector that allows cloning 
of target DNAs at sites where they will be minimally trdnscribd by 
RNA polymerase but sclcctivcly and aclivcly transcribed by l-7 RNA 
polymcrase in BL21 (DE3) [16]. WC fused a mTIMP-I cDNA (with 
its own leader sequence liminated) between the /v&l and f?umHI silts 
of PET-3c. This cDNA. derived from mouse embryo fibroblasts 1171, 
was placed under the control of the T7 promoter (910) of the vector 
(Fig. 1). The resultant TIMP-I expression vector, PET-3cT, was lrm- 
formed into E, coli BL2 I pLysS [ 181 and sclectrd for ampicillin rcsis- 
tancc. 
Cmqmrhrr~ address: D.T. Dcnhardt. Department of Biological 
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2.2. Rmmry of rccantbinmtr at TIMP-I Jiara hcbrsian bodies 
E. c-u/i BL21 cells transformed with PET-3cT plasmid were grown 
at 30°C overnight in shaker flasks in medium conlaining 10 g of 
tryptonu,5GofNaCI,l9mM NH,Cl.360TKI~2P0,,G60TNa,HP0,. 
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4 g of glucose, 1 mM MgSO, per liter (M9.25 medium) and 75Wml 
carbenicillin. The culture was induced with 0.4 mM 1 PTG for 4 11 after 
it reached an OD, of 0.5. The cells were centrifuged at 4.400 x g for 
15 min at 4OC, resuspended in 80 ml oflysis bulTer (50 mM Tris-HCI, 
pH 8.3, 5 mM EDTA, 0.3 M N&l) - per 500 ml of original culture 
volume - and sonicated (15-20 s pulses at 40% maximum intensity) 
using II Sonic Dismcmbrator (Model 300) before being frozen at 
-70°C for 30 min, After partially thawing the bacteriid cell lysatc a1 
37°C. 100~1 of 100 mM phcnylmcthane-sulphonyl fluoride wasadded 
and the mixture allowed to sit on ice for 20 min, Four ml of 10% NP-40 
(in lysis bul’fer) were then added, and the mixture allowed to sit on ice 
for another 30 min, Afler brief sonication, the solurion was centrifuged 
at 18.000 xg for 20 min and the pellet resuspended in 20 ml of 10 mM 
Tris-HCI (pH 8.0)/l M NaCl. The solution was centrifuged at 20,000 
x g for I5 min and the pellet resuspended in 5 ml of solubillzilGon 
buffer (8 M urea, 50 mM Tris-HCI. pH 7.5, and 0.1 M 8.mercap- 
toethanol). Aficr incubation overnight at 4°C the insoluble material 
was removed by ccntrifugalion ai 31,000 x s for 20 min. 
2.3. Purtflcatiort und rrttarwotion of mTfMP-i 
The supernatant from the 3 1,000 xg spin was applied to a Bio-Rex 
70 column equilibralcd with 8 M urea, 50 mM Tris-MCI, pH 7.5, and 
50 mM ,&mercsploclhanol. Samplcs (120 mg protein) were loaded 
into a 2.6 x 4.2 cm column and washed extensively. The column was 
eluted with 0.25 M NaCl in this snmc buffer. Fractions (2 ml) were 
collected and assayed for protein content by the Bradford method. 
Fractions containing protein were then analyzed by elcctrophoresis on
an SDS-20% polyacrylamidc gel using the Pharmacis Phase System 
[19]. Fractions containing TlMP-1 (based on the mobility of proteins 
in 20% acrylamidc ‘Phast’ gels) were pooled. 
A modified procedure of Kohno et al. [?O] was used to refold 
mTIMP-1. /?-Mercnptocthonol was added LO the mTIMP-I cnrichcd 
protein solution to a conccmmlion of 140 mM in 6 M urea, 50 mM 
Tris-MCI, pH 75. The protein was then diluted LO 200pg/ml with the 
same buffer and cystamine was added LO 292 mM. This solution was 
gently rocked in SO-ml Falcon cuhure tubes overnight at 4°C lo form 
mixed disulflde derivatives of TIMP. The next day urea was gradually 
diluted whh 50 mM Tris-HCI. oH 9.0 lat about 50 ml/30 min) LO 0.3 
M at 4°C to initiate refoldi&.‘Thc protein solution (10 ,&&I) was 
then exposed to air without stirring at 4’C for 24 h to allow reshuffling 
of mismaWicd isulfide bonds. Following the overnight incubation, 
the protein solution was concentralcd by ultrafiltration on an Amicon 
YMIO membrane to about 15% of its volume und then concenwated 
LO its final volume (20.fold overall) in Centricon- devices which had 
been previously trcalcd with 5% Triton X-100. The buff.er solution was 
then exchanged by dialysis to 50 mM Tris-HCI, pl-I 7.5 (4 x 4 liters). 
The protein was ihcn examined by SDS-PAGE on the Pbast system. 
Further purification was by reverse pbnsc HPLC: a linear gradient of 
0.05% TFA in water to 0.05% TFA in acetoniirilc was used to elulc 
the column, 
2.4. Atrulysis of refolded rccmbitruttt tuTIMP- for activity 
To determine the inhibitory activity of mTIMP-I, rat tail collagen 
(type 1) which was ‘H-labeled by the method of Birkcdal-Hansen and 
Dano [21] was incubated overnight nt room tcmpcrature withp-amin- 
ophcnylmcrcuric a etalc-activated human collagenase inthe prcsencc 
or absence of mTIMP-1. The ettent of cleavage of the a, and a* 
subunits of collagen I to the a,A and o,A fragments was analyzed by 
SDS-PAGE of the reaction mixtures using the Phast system, followed 
by aulorudiugr&phy and densitomrtry of the autoradiogrem. Pcrccnt 
inhibition of collugcn digestion by collagcnasc was calculated by lhc 
following formula: 
% inhibition = (% collagen degradation by standard collagenase) - (% 
degradalion in the presence of inhibitor)/(% collngen degradation by 
standard collagenasc) 
3. RESULTS 
Examination of the bacterial ysates by SDS-poly- 
acrylamide gel electrophoresis for the presence of pro- 
tein with an apparent molecular weight of about 22 kDa 
(indicative of mTIMP-1) revealed that E. co/i BL21 cells 
transformed with pET3cT plasmid (Fig. I) expressed 
mTIMP-1 protein when induced with IPTG (Fig. 2; 
Inset: lane 2). Based on several gel scans with an LkB 
Ultrascan Laser densitometer (data not shown), this E. 
coli strain appeared to produce recombinant mTIMP-1 
at about lO-15% of total cell protein. 
Partial purification by cationic exchange on Bio-Rex 
70 of the urea-solubilized inclusion bodies (Fig. 2) re- 
sulted in >90% enrichment of mTIMP-1 protein (Fig. 
2; Inset: lane 5). Refolding of this partially purified 
protein by gradual dilution of the urea (to 0.3 M) al- 
lowed more than 40% of the protein to remain soluble 
in denaturant-free buffer after extensive dialysis. SDS- 
polyacrylamide gel electrophoresis of this refolded ma- 
terial under reducing conditions howed predominantly 
one protein band (Fig. 2; Inset: lane 6) indicative of no 
significant degradation of mTIMP- 1 during refolding. 
A more compact protein structure may account for the 
anomalous migration (slightly higher mobility) of re- 
folded TIMP-I. Similar banding patterns of mTIMP-1 
under both reducing and non-reducing conditions (data 
not shown) indicated a primarily monomeric protein 
species. 
Final purification of mTIMP-1 was accomplished 
using reverse-phase HPLC (Fig. 3). The HPLC-purified 
mTIMP-1 protein (Fig. 3; Inset: lane 3) migrated on 
SDS-PAGE similarly to human TIMP-1, henceforth 
written as hTlMP-1 (Fig, 3; Inset: lane 2). This HPLC- 
purified mTIMP-1 was more than 95% pure as judged 
by gel scanning (data not shown). 
Fig. 1. Struclure of the PET-3cT expression vector. The T7 DNA 
segment of this vector comains the @IO promoter plus the ~10 transla- 
tion inilialion region for the gene 10 protein and the T@ transcription 
termination signal. mTIMP-1 is joineddirectly to thcgene 10 initiation 
codon at the Ndel site. 
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Fig. 2. Cationic-exclrangc chromatography of recombinant mTIMP.1. 
Solubilized inclusion body protein was applied to a 2.6 x 4.2 cm 
Bio-Rex 70 column and &ted with 0.25 M NaCI. Fractions of 2 ml 
were collected and assayed for protein. Inset: SDS-polyacrylamide g l 
elcctrophorcsis oTmTIMP-I on a Phast 20% gel, (Lane I) Uninduced 
cell lysatc ol’ E. culi B2l(DE3) cells iransi’onncd with PET-3cT, (lane 
2) cell lysatc of transformed cells induced with 0,4 mM IPTG; (lane 
3) aolubilizcd inclusion body protein iYom induced cells; (Inne 4) flow- 
through o~solubilized inclusion body protein applied to the cationic 
exchanger: (lane 5) denatured mTIMP-I protein clutcd rrom the urea- 
equilibrated Bio-Rex 70 column will1 025 M NaCI; (Ianc 6) soluble 
(denaturant-free) r combinant mTIMP-I refolded by dilution. Arrow 
indicates the position of mTIMP-I. 
Assays to determine the ability of the refolded 
mTIMP-I protein to inhibit the degradation of collagen 
by interstitial collagenase were performed in order to 
assess the efficiency of renaturation. As indicated in Fig. 
4, HPLC-purified, refolded mTIMP-1 possessed inhib- 
itory activity. Although inhibitory activity by mTIMP-1 
was not observed with undiluted collagenase (Fig. 4, 
lane 3), in contrast o hTIMP-1 (Fig. 4, lane 2), inhibi- 
tion was apparent (Fig. 4, lane 6) when the collagenase 
was diluted by one half (Fig. 4, lane 4), i.e. under condi- 
tions such that the collagen subunits were only partially 
degraded. On closer examination {Fig. S), mTIMP-1 
displayed a much lower specific activity (for 50% inhibi- 
tion, a ratio of TIMP-1 to collagenase of about 190/l 
was needed) than hTlMP-1 (a ratio of TIM&l to col- 
lagenase of about 1.4/l for 50% inhibition). 
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Fig. 3. HPLC oi’ refolded recombinant raTIMP-I. Approximately 0.7 
rn6 of refolded TIMP-1 was applied to a IO mm x I5 cm semi-prep 
column of C,,-ultrasphere (Beckman) equilibwtcti in O.OSQ TFA. A 
linear gradient of acetonilrile containing 0.05% lriiiuoroacotic acid 
was used to elutc the protein. The flow rate was maintained at 1 
Wmin, and 2 ml fractions were collected. Absorbance was recorded 
at 229 nm and peak areas evaluated by a Beckman 427 integrator. 
Inset: SDS-PAGE oi’ refolded recombinant mouse TIMP-1 after final 
purification by HPLC. (Lane 1) Low molecular weight markers: (lane 
2) hTIMP-1; (lane 3) mTIMP-I which was puriiied by HPLC. 
1.. .2 .d 4 5 6 
~-lg, 4, Analysis by SDS-PAGE of the inhibitory activily of reeombi- 
nant mouse TIMP-1. One microlitcr aliquots or HPLC-purified inhib- 
itor were incubated overni&ht with 0.50,~l of APMA-activated human 
collagcnase inthe presence of 5~1 of labeled collagen (I 5.OPO cpm, 2.5 
~8) and 5 mM CaC& to determine the extent ofcollagcn dcgradntion. 
Total reaction volumes: 10 ~1. (Lnnc 1) Collagen plus undiluted 
collagenasc: (lane 2) collagen, undiluted callagenase plus hTIMP-I; 
(lane 3) collagen, undiluted collagenase plus mTIMP-I; (lane 4) colla- 
gen plus I: I diluted collagenase; (lane 5) collagsn, I: 1 diluted colla- 
gcnasc plus hTIMP-I; (lane 6) collugen, I:1 diluted collagcnase plus 
mTlMP- I. 
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Fig. 5. Assessment of the specific nclivity of purified mTIMP-1. In- 
creasing amounts of hTIMP-I or mfIMP-I were insubaied overnight 
with citbcr I .3 x IO-” nmol (in the case of hTIMP*1) or I .7 x IOaJ nmol 
(in the case of mTIMP-I) of human collagcnasr. which was rate- 
limiting here. and then assayed forcollagenolysis inhibiiion. The tailed 
arrows indicule rhc amount oTTIMP- protein needed to achieve 50% 
inhibilion of collagen degradation by collagenasc. 
4. DISCUSSION 
The overall yield of active mTIMP- I obtained by our 
method represents about 0.5%. Far ultraviolet circular 
dichroic spectra of refolded, HPLC-purified mTIMP-I 
at different pHs [19] revealed that at the physiological 
pH range (pH 6.5-7.5) a pH-induced conformational 
change occurred (data not shown) in the recombinant 
protein as reflected by a large increase in random coil 
secondary structure. Since native, glycosylated mTIMP-1 
is normally stable at physiological pH, the conforma- 
tional change observed here suggests that although 
some of the protein can refold properly, most ol’ it is in 
an inactive. relatively unstable, state. 
The fact that recombinant hTIMP-I is appurcntly 
more efficiently refolded [20] than recombinant 
mTIMP-I (mTIMP-I is about 30% non-l~o~~~ologous al 
the amino acid level with respect to hTIMP- I [31]) 
might mean that it contains an amino acid sequence hl 
allows more thermodynamically fuvorublc or slable 
conformations to occur, Allernatively. ihc low spccilic 
activity of recombinant mTIMP-1 may rcAcct he accu- 
mulation of intermediate conformations wiih mis- 
matched isulfidcs that tempor;llly sltibiiizc slruciurcu 
that are not at the global minimum cncrgy lcvcl and 
whose rates of rearrungcmcnt to bob LIIC correct num- 
ber and types ofdisulfidc bonds norn?ally found associ- 
ated with the final nutivc produci arc exlrcmcly low. 
The conformers accumulating here can be viewed as 
structures akin to kinetic folding mutants of TIMP-1, 
Arknu~~(crl~~rrrr/~is: This research was supported by funds from 
Rutgers University and by AGO7972 and CA50183 from the National 
Institutes of Health. We thank William Studier for making available 
rhc plasmid pET-3c. Richard Berg for providing !rhium.labeled colla- 
gen, Howard Wclgus for generous gifts of human interstitial collage- 
nusr, and David Cnrmichael and his colleagues at Synergen for their 
kind help and advice. 
REFERENCES 
[I] Hay, E.D. (1981) J. Cell Biol. 91. 205s~233s. 
[2] Wcrb, Z. (1989) in: Textbook of Rheumatology (Kelley, W.N., 
Harris Jr.. E.D. and Sledge, C.B. cds.) 3rd cdn., pp, 300-321, 
Saunders, Philadelphia, 
[3] Murphy, G., Cartwright, EC., Sellers, A. and Reynolds, J.J. 
I 1977) Biochem. BioDhvs. Acta 483.493-498. 
[4] .&ricklin. G.P. and ‘W&us, H.G. .(1983) J. Viol. Chem. 255, 
12?52-1258. 
[S] Cawslon, TX., Galloway, W.A., Merccr. E., Murphy, Ci. and 
Reynolds. J.J, (I981 j Biochcm. J. 195, 159-165. 
IG] Murphy, G. and Werb, Z. (1985) Biochim. Biophys. Acra 839, 
214-218. 
[7] Campbell, E,J,, Cury, J.D., Lazarus, C.J. and Welgus, H.G. 
119871 J. Dial. Chcm. 262. 15X62-15868. 
[E] ‘He&n. GS,, Banda, M.J:, Clark, E.J.,~&.vrilovic, J. and Werb. 
2. (19Y6) J. Dial. Chem. XII, 28142818. 
[9] Stcrlcr-Slcvcnson, W,Ci., Krutesch, 1-X and Liotia, L.A, (1989) 
J. Viol. Chem. X4, 17374-1737s. 
[IO] Steller-Stcvcnson, W,G,. Brown, P.D.. Onisto, M., Levy, A.T. 
and Lioiia, L.A. (1990) J. Biol. Chem. 265. 13935-13938. 
[I I] Khokha. R.. Walerhouse, P,. Yngel, S., Lala, P.K., Overall, 
CM,. Norton. G. and Dcnhardi, D.T. (1989) Science 243, 947.- 
950. 
[I?] Ilalakn, A.N.. Bunning, R,A.D., Bird, CC., Gibson. M. and 
Reynolds. J.J. (1983) !. Ncurosurg. 59.461466. 
[I?+] Hicks. N,J., Ward, R.Y, and Reynolds. J.J. (1984) Int. J. Cancer 
33.833-844. 
[14] Murphy. G,, Hoybrcchts, A., Cockcit, M.I., Williamson, R.A,, 
O’Shea. M. and Docheny. A.J.P. (1991) 13iochemis&y 30, 8097- 
8101. 
[I 51 Williamson. R-A., Marsion, F.A.O.. Angal. S.. Koklitis. P., Pa. 
nice. M.. Morris, H.R., Came, A.F., Smith, B.J., Harris, T.J.R. 
and Freedman, R.B. (1990) Diochem. J X8, 267274. 
161 Roscnbcrg. A.H., Lode, B.N., Chui, D,S., Liu, S,W,, Dunn, J.J. 
and Siudicr. F,W. (1987) Gene 56, 125-135. 
171 Edwards. DR,. Walerhouse, P., Holmun, M.L. and Denhardt, 
D.T. ! 1956) Nucleic Acids Res. 14, f3863-8878. 
181 Sludicr. F.W., Rosenberg, A.H.. Dunn, J.J. and Dubcndorll; 
J.W. (1990) Methods Enzymol. 185, GO-89. 
191 Cocuzzi, E.. Walthcr. S., Rajan. S., Emanuel. 5. and Denhardt. 
D.T. (1991) 5th Symp. Protein Sac. (Abstr. 550, p, 70), 
[10] Kohno, T.. Curmichael, D.F., Sommer, A. and Thompson, R.C. 
(1990) Mchods Enzymol. 185, 187-195. 
I211 Gcwerl, D.R., COulOmbe, B., Custelino, M.. Skup, D. and Wil. 
liars. B.R. (1957) EMBO J. G, 65l-GS7. 
378 
